tumor

Faeth Therapeutics closes $20M seed to turn nutrition into a pillar of cancer treatment

A hot bowl of pad thai simmers in front of you. The taste and texture is exactly what you might expect from a quick takeout dinner, but it’s not just a meal — it’s medicine. This hypothe

C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series B

If you or a loved one has ever undergone a tumor removal as part of cancer treatment, you’re likely familiar with the period of uncertainty and fear that follows. Will the cancer return, and if so,

Immunai wants to map the entire immune system and raised $20 million in seed funding to do it

For the past two years the founding team of Immunai had been working stealthily to develop a new technology to map the immune system of any patient. Founded by Noam Solomon, a Harvard and MIT-educated

NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic

Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from the U.S. Food and Drug Admin

Pitching accuracy rates of over 99% for multiple cancer screens, Thrive launches with $110 million

For more than 25 years the founders of Thrive Earlier Detection have been researching ways to improve the accuracy of liquid biopsy tests. The fruits of that labor from Dr. Bert Vogelstein, Dr. Kennet

Healthcare by 2028 will be doctor-directed, patient-owned and powered by visual technologies

Visual assessment is critical to healthcare -- whether that is a doctor peering down your throat as you say “ahhh” or an MRI of your brain.

Companies tracking mutations in cancer cells can provide a key to unlocking better therapies

Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through the identification of mutations in cancer cells that can creat

Implantable 3D-printed organs could be coming sooner than you think

At MBC Biolabs, an incubator for biotech startups in San Francisco’s Dogpatch neighborhood, a team of scientists and interns working for the small startup Prellis Biologics have just taken a big

Tradewind BioScience attacks the physiology of tumors to treat cancer

Cancer remains the one counterpoint to the march of medical progress that has scored human history over the last 200 years. Last year 600,920 people in the U.S. died from cancer, and another 1.7 milli

All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti

A who’s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors. Led by Tim Lu, a

Strange CPU monitor is not a tumor

<img src="http://www.crunchgear.com/wp-content/uploads/2009/09/yo02.jpg" />No, it's not a physical manifestation of a computer virus. Made by Japanese artist Mio I-zawa, the mechanical tumor serves as